Date: Apr 08, 2010 Source: xConomy (
click here to go to the source)
Amplyx Pharmaceuticals, a San Diego-based drug developer, has raised an initial round of $1.5 million in financing. The investors included Golden Seeds, Life Science Angels, and Tech Coast Angels. The company, led by CEO Elaine Heron, is developing technology to improve existing drugs by controlling their concentration and time they hit their targets, according to a statement. The company noted that Golden Seeds is a national angel investment network that invests in women-led companies.
